✦ LIBER ✦

Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer

✍ Scribed by Mari Nakabayashi; Wanling Xie; Meredith M. Regan; David M. Jackman; Philip W. Kantoff; William K. Oh

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 92 KB
Volume: 107
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.22085

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intermittent chemotherapy in patients wi

Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer : Results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel

✍ Tomasz M. Beer; Christopher W. Ryan; Peter M. Venner; Daniel P. Petrylak; Gurkam 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract ## BACKGROUND. Survival in patients with metastatic, chemotherapy‐naive, androgen‐independent prostate cancer (AIPC) is improved with 10 to 12 cycles of docetaxel‐containing chemotherapy but further management is undefined. In the current study, the authors examined retreatment with th

Erratum: Milano GM, Cozza R, Ilari I, et

Erratum: Milano GM, Cozza R, Ilari I, et al. High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk ewing sarcoma family tumors: The Bambino Gesù Children's Hospital experience. Cancer. 2006;106(8):1838–45.

📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 24 KB 👁 1 views